MSK is offering COVID-19 vaccines to New Jersey and New York State patients. Use this link to schedule. For NY State patients aged 16-17, a parent/guardian must call their doctor’s office to schedule. For more info, and if you live in NJ read this.
Taiwan Veterans General Hospital Research Scholarship
Attending Physician, Taichung Veterans General Hospital, Taichung, Taiwan
Lee MC, Aly RG, Adusumilli PS. New staging system for pulmonary neuroendocrine tumors: A clinical and pathologic necessity. J Thorac Cardiovasc Surg. 2018 Jan;155(1):367-368.
Eguchi T, Bains S, Lee MC, Tan KS, Hristov B, Buitrago DH, Bains MS, Downey RJ, Huang J, Isbell JM, Park BJ, Rusch VW, Jones DR, Adusumilli PS. Impact of increasing age on cause-specific mortality and morbidity in patients with stage I non-small cell lung cancer: a competing risks analysis. J Clin Oncol. 2017;35(3):281-90.
Ujiie H, Kadota K, Chaft JE, Buitrago D, Sima CS, Lee MC, Huang J, Travis WD, Rizk NP, Rudin CM, Jones DR, Adusumilli PS. Solid predominant histologic subtype in resected stage I lung adenocarcinoma is an independent predictor of early, extrathoracic, multisite recurrence and of poor postrecurrence survival. J Clin Oncol. 2015;33(26):2877-84.
Kadota K, Buitrago D, Lee MC, Villena-Vargas J, Sima CS, Jones DR, Travis WD, Adusumilli PS. Tumoral CD10 expression correlates with high-grade histology and increases risk of recurrence in patients with stage I lung adenocarcinoma. Lung Cancer. 2015;89(3):329-36.
Lee MC, Buitrago DH, Kadota K, Ujiie H, Woo K, Sima CS, Travis WD, Jones DR, Adusumilli PS. The tumor immune microenvironment in octogenarians with stage I non-small cell lung cancer. Oncoimmunology. 2014;3(11):e967142.
Lee MC, Kadota K, Buitrago D, Jones DR, Adusumilli PS. Implementing the new IASLC/ATS/ERS classification of lung adenocarcinomas: results from international and Chinese cohorts. J Thorac Dis. 2014;6(Suppl 5):S568-80.
Lee MC, Buitrago DH, Kadota K, Jones DR, Adusumilli PS. Recent advances and clinical implications of the micropapillary histological subtype in lung adenocarcinomas. Lung cancer management. 2014;3(3):245-53.